E100 Melissa Landon, VP and Chief Strategist at Cyclica

Today's guest is Melissa Landon, VP and Chief Strategist at Cyclica. Cyclica is a Toronto-Based globally recognized biotechnology company that leverages AI and computational biophysics to reshape the drug discovery process. Cyclica's proprietary structure-based and AI-augmented drug discovery platform includes Ligand Design for multi-targeted and multi-objective drug design, and Ligand Express for off-target profiling, systems biology linkages, and structural pharmacogenomic insights.

Taken together, Ligand Design and Ligand Express design advanced lead-like molecules that minimize unwanted off-target effects, while providing a holistic understanding of a molecule's activity through integrated systems biology and structural pharmacogenomics. By doing more with Artificial Intelligence, Cyclica aims to revolutionize a system troubled with attrition and costly failures, accelerate the drug discovery process and develop medicines with greater precision.

In the show, Melissa will tell you about:

The fascinating work they are providing in the biotech industry,

What makes them stand out from the competition,

How they are applying Machine Learning and Data Science at Cyclica,

What attracted her to join Cyclica,

Upcoming projects & what’s in store for the future,

and How AI & Data Science will continue to positively disrupt the HealthTech sector.